October 10, 2017 6:16pm

… The sector closed positive

As I had stated, “Traders were back at their desks and looking at the overbought while eyeing the oversold after a thinly traded session!”

 

Pre-open indications: 4 hit and 3 miss (by pennies)

 

In the grip of rotating cycles and disparaging trends, what is the price of sector knowledge – a subscription!  

 

Tuesday’s results have implications to Wednesday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

 

Henry’omics:

From the pre-open’s newsletter “Trades in sector equities are precursors of news, not the other way around!”

When the sector was directionless and moribund; luckily it was recognized. If you had been right as many times as I have been in these many months of 2017 as a SUBSCRIBER you would know when to get in and out or get back in again! 

The way forward cannot be found in the practices and spending of the past as the sector is operating and defined by its own contradictions.

Each of the contradictions can be traced to its dependency on capital market access!

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The open was positive with an A/DL of 20/18 and 5 flats;

·         First hour was positive with an A/DL of 20/19 and 4 flats;

·         The mid-day was negative with an ADL of 19/21 and 3 flats;

·         The close was positive with an A/DL of 23/19 and 1 flat;

 

Pre-open indications: 4 hit and 3 miss

  • Adverum (ADVM) closed up +$0.10 – miss;
  • Capricor (CAPR) closed down -$0.21 – hit;
  • Cytori Therapeutics (CYTX) closed up +$0.02 – hit;
  • Cesca Therapeutics (KOOL) closed up +$0.08 – miss;
  • MiMedx (MDXG) closed up +$0.63 – hit;
  • Spark Therapeutics (ONCE) closed up +$1.07 – hit;
  • Sangamo Therapeutics (SGMO) closed up +$0.05 – miss;

 

 

Some of MY working trend lines or indications:

… The greatest volume to the downside:  IMUC, ONVO, ATHX, JUNO and CAPR

… Upside volume was weighted to:  MDXG, BSTG, CYTX, PSTI and SGMO

… Biggest $ downside: JUNO (-$0.49), ONVO (-$0.25), CAPR (-$0.21), ATHX (-$0.19) and VTGN (-$0.16)

… Largest $ upside:  ONCE (+$1.07), RGNX (+$0.75), MDXG (+$0.63), MESO (+$0.61) and CLLS (+$0.44)

… Flat:  KITE

 

 

Counting the week’s apples:

CAPR closed down again -$0.21 after Monday’s -$0.19 - CAPR can’t keep fooling investors for long with their brand of hype …

VCEL was up +$0.05 after Monday’s -$0.40 – still believe an Icarus flight path and should have financed in an overnight … short sighted management

As HSGX closed down -$0.02 after Monday’s -$0.07 after a week of ups (+$0.21) … traders became nervous …

While AXGN was up +$0.05 after being flat On Monday again while MDXG regained momentum with a +$0.61 jump after being down -$0.41 … the merry-go-round turns;

AGTC was down -$0.15 again after Monday’s +$0.05 and being flat at $4.00 on Friday. I haven’t seen or heard of ANY officer buys … AGTC can’t escape the downside trap …

AST was down again -$0.05 while mothership BTX was down -$0.03 post being up +$0.04 … they both NEED cash to prop their balance sheets

Cellectis S.A. (CLLS) jumped +$0.44 after being down -$0.19 after Friday’s -$0.28 as I had stated … watch the merry-go-round, wait for the music to stop;

Immuno-oncologists - JUNO was down -$0.49 after Monday’s +$0.07 after Friday’s -$1.11; as VSTM jumped +$0.06 after slipping -$0.01 on Monday after Friday’s -$0.14;

ATHX was declined -$0.19 after being flat after Friday’s -$0.03 as many STILL question their cash position going forward and their clinical “manufacturing” issues as trials continue …

RGNX was up +$0.75 after being down -$1.35 after Friday’s +$0.50 opting to back away from a deal to buy Dimension Therapeutics Inc. (DMTX). RGNX had announced plans to buy Dimension in an all-stock transaction.  Any time one has a doubt – wait, RGNX usually rebounds … by walking they receive $2.85 M … I keep telling you to stay!

SGMO was up +$0.05 after getting slashed -$0.10 after Friday’s -$0.70 while ONCE was up +$1.07 after Monday’s -$1.77 after Friday’s -$0.04 as BLUE jumped again +$0.15 post being +$3.75 after Friday’s +$1.75 …

FATE was down -$0.02 following Monday’s +$0.06 after Friday’s -$0.08 – hang in;

MESO regained altitude +$0.61 after Monday’s -$0.06 after Friday’s -$0.30 – as I stated time to be accumulating …

PSTI was up +$0.08 after Monday’s +$0.07 after Friday’s down -$0.01 after being flat at $1.50 after being up +$0.03 following rumor of selling some product assets…

 

 

Daily analytics:

All main U.S. stock indexes closed higher on Tuesday, with the Dow finishing at its 47th record for 2017. Highlighting a recent uptrend in equities, the S&P 500 has risen in nine of the past 11 sessions and the NASDAQ has gained in 10 of the past 11.

·         The Dow rose 69.61 points, or 0.3%, to end at 22,830.68.

·         The S&P 500 added 5.91 points, or 0.2%, to close at 2,550.64.

·         The NASDAQ reversed earlier losses to finish 7.52 points, or 0.1%, higher at 6,587.25.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market; Tuesday traded at 10.08, down -2.42% …

  • Monday traded at 10.33, up +7.05% after Friday traded 9.65, up +5.01% after Thursday traded at 9.19, down -4.57% after Wednesday traded at 9.63, up +1.26% after last Tuesday traded at 9.57, up +1.27 …

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Tuesday was up +0.27%

·         Monday -0.41%

·         Friday -0.11%

·         Thursday +0.27%

·         Wednesday -0.30%

·         Last Tuesday +0.21%

 

… The Russell 2000 (RUT)

·         Tuesday gained +4.44 or +0.30%

·         Monday lost -6.66 or -0.44%

·         Friday lost -1.87 points or -0.12%

·         Thursday gained 4.32 points, or 0.3%

 

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Tuesday was up +0.03%

·         Monday -0.29%

·         Friday -0.11%

·         Thursday +0.11%

·         Wednesday +0.78%

·         Last Tuesday -0.23%

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %

·         Tuesday’s decliners ranged from -0.42% <XON -$0.08> to -12.82% <ONVO -$0.25)> in 19 equities;

·         Monday’s decliners ranged from -0.22% <VSTM -$0.01> to -14.95% <CYTX -$0.0949> in 26 equities;

·         Friday’s decliners ranged from -0.05% <ONCE -$0.04> to -52.40% <BSTG -$0.119> in 28 equities;

·         Thursday’s decliners ranged from -0.05% <ONCE -$0.04> to -24.99% <BSTG -$0.08> in 21 equities;

·         Last Wednesday’s decliners ranged from -0.42% <JUNO -$0.19> to -8.32% <KOOL -$0.40> in 16 equities;

·         Last Monday’s decliners ranged from -0.01% <KITE -$0.02> to -8.66% <BLUE -$11.90> in 14 equities;

Versus

… Look at the percentage’s (%) and spreads …

·         Tuesday’s gainers ranged from +0.11% <BLUE +$0.15> to +10.02% <MESO +$0.61> in 23 equities;

·         Monday’s gainers ranged from +0.16% <JUNO +$0.07> to +12.12% <RENE.L +$0.20> in 13 equities;

·         Friday’s gainers ranged from +0.36% <BTX +$0.01> to +29.55% <CYTX +$0.14> in 12 equities;

·         Thursday’s gainers ranged from +0.22% <OSIR -$0.01> to +24.49% <CYTX +$0.10> in 20 equities;

·         Wednesday’s gainers ranged from +0.42% <VCEL +$0.025> to +6.38% <CYTX +$0.023> in 22 equities;

·         Last Tuesday’s gainers ranged from +0.31% <XON +$0.06> to +33.98% <KOOL +$1.22> in 18 equities;

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.